Drug Shortage Report for ALOXI
Report ID | 107574 |
Drug Identification Number | 02381729 |
Brand name | ALOXI |
Common or Proper name | Aloxi |
Company Name | KNIGHT THERAPEUTICS INC. |
Market Status | DORMANT |
Active Ingredient(s) | PALONOSETRON |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 1 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-03-02 |
Actual start date | 2020-03-02 |
Estimated end date | 2020-04-30 |
Actual end date | 2020-03-27 |
Shortage status | Resolved |
Updated date | 2020-04-02 |
Company comments | Testing Method change has resulted in additional testing requirements. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-02 | English | Compare |
v2 | 2020-03-02 | English | Compare |
v3 | 2020-03-02 | French | Compare |
v4 | 2020-03-03 | English | Compare |
v5 | 2020-03-24 | English | Compare |
v6 | 2020-03-24 | French | Compare |
v7 | 2020-04-02 | English | Compare |
v8 | 2020-04-02 | French | Compare |
Showing 1 to 8 of 8